These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19055570)

  • 1. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.
    Jessen LR; Wiinberg B; Jensen AL; Kjelgaard-Hansen M; Jensen KH; Pedersen LB; Kristensen AT
    Vet Clin Pathol; 2008 Dec; 37(4):363-72. PubMed ID: 19055570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparinase-modified thromboelastography in cats.
    Cuq B; Dunn ME; Bédard C
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):127-130. PubMed ID: 28002635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs.
    Brainard BM; Koenig A; Babski DM; Blong AE; Scherk JR
    Am J Vet Res; 2012 Oct; 73(10):1577-82. PubMed ID: 23013183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses.
    Tennent-Brown BS; Epstein KL; Whelchel DD; Giguère S
    J Vet Emerg Crit Care (San Antonio); 2013; 23(3):291-9. PubMed ID: 23656212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography.
    Johansson PI; Bochsen L; Andersen S; Viuff D
    Transfusion; 2008 Nov; 48(11):2377-83. PubMed ID: 18657078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of native and citrated whole blood samples for rapid thromboelastography in Beagles.
    Wang H; Nam A; Song K; Youn HY; Seo KW
    J Vet Emerg Crit Care (San Antonio); 2020 Jan; 30(1):54-59. PubMed ID: 31845529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dalteparin on thromboelastography in pregnancy: an in vitro study.
    Chow L; Carr A; MacKenzie L; Walker A; Archer D; Lee A
    Int J Obstet Anesth; 2016 Dec; 28():22-27. PubMed ID: 27717636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs.
    Wiinberg B; Jensen AL; Rojkjaer R; Johansson P; Kjelgaard-Hansen M; Kristensen AT
    Vet Clin Pathol; 2005 Dec; 34(4):389-93. PubMed ID: 16270265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activation.
    Marschner CB; Bjørnvad CR; Kristensen AT; Wiinberg B
    Acta Vet Scand; 2010 Jun; 52(1):38. PubMed ID: 20529334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.
    Feuring M; Wehling M; Schultz A
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):783-6. PubMed ID: 21883380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use.
    Bauer N; Eralp O; Moritz A
    J Vet Diagn Invest; 2009 Sep; 21(5):641-8. PubMed ID: 19737759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile.
    Gerotziafas GT; Chakroun T; Samama MM; Elalamy I
    Thromb Haemost; 2004 Dec; 92(6):1296-302. PubMed ID: 15583737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of citrated native and kaolin-activated samples for thrombelastographic analysis in healthy dogs.
    Flint SK; Wood RD; Abrams-Ogg AC; Kruth SA; Bersenas A
    Vet Clin Pathol; 2012 Jun; 41(2):249-55. PubMed ID: 22551328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing citrated native, kaolin-activated, and tissue factor-activated samples and determining intraindividual variability for feline thromboelastography.
    Banerjee A; Blois SL; Wood RD
    J Vet Diagn Invest; 2011 Nov; 23(6):1109-13. PubMed ID: 22362790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low molecular weight heparin on clot rate and activated clotting time: an in vitro study.
    Shi XB; Bai Y; Li J; Xiao J; Wang JQ; Zheng H
    Chin Med J (Engl); 2013; 126(18):3553-6. PubMed ID: 24034107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples.
    Wasowicz M; Srinivas C; Meineri M; Banks B; McCluskey SA; Karkouti K
    Can J Anaesth; 2008 May; 55(5):284-9. PubMed ID: 18451116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass.
    Chavez JJ; Foley DE; Snider CC; Howell JC; Cohen E; Muenchen RA; Carroll RC
    Anesth Analg; 2004 Nov; 99(5):1290-1294. PubMed ID: 15502019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses.
    Leclere M; Lavoie JP; Dunn M; Bédard C
    Vet Clin Pathol; 2009 Dec; 38(4):462-6. PubMed ID: 19548973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.